Acute lymphoblastic leukaemia. Acute lymphoblastic leukaemia [ALL]
Conditions
Interventions
Intervention 1: Intervention group: The intervention, performed in this study, is a family-based support program (Including family and patient education, determining the type of patient's diet, and ps
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for patients: Have age over 18 years old Being able to understand and speak Persian and have the ability to read and write Have awareness of time, place and person Consent to participate in the study Acute lymphatic leukemia have been diagnosed for them For chemotherapy, at least, one of the family members who take care of patient at home accompanies him/her Have been referred to chemotherapy clinic and have being under consolidation chemotherapy Be the first or second turn of consolidation chemotherapy for these people Family members Inclusion Criteria: Have age between 18 to 60 years old Ability to understand Persian language and speak Persian, have ability of reading and writing Being aware of time, place and person being one of the first degree relatives of patient, and providing patient care at home and willing to participate in the study The patient obeys the relative They are personnel of the health system
Exclusion criteria
Exclusion criteria: Patients exclusion criteria: Have history of Chemotherapy in family members being one of the health system personnel Family member exclusion criteria: being one of the health system personnel
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea or vomiting before treatment. Timepoint: Before starting the first or second chemotherapy sessions, and then in each chemotherapy session until 3 months - number of chemotherapy sessions depend on the chemotherapy protocol. Method of measurement: The Chemotherapy Symptom Assessment Scale.;Nausea after treatment. Timepoint: Before starting the first or second chemotherapy sessions, and then in each chemotherapy session until 3 months - number of chemotherapy sessions depend on the chemotherapy protocol. Method of measurement: The Chemotherapy Symptom Assessment Scale.;Vomiting after treatment. Timepoint: Before starting the first or second chemotherapy sessions, and then in each chemotherapy session until 3 months - number of chemotherapy sessions depend on the chemotherapy protocol. Method of measurement: the Chemotherapy Symptom Assessment Scale.;Constipation. Timepoint: Before starting the first or second chemotherapy sessions, and then in each chemotherapy session until 3 months - number of chemotherapy sessions depend on the chemotherapy protocol. Method of measurement: the Chemotherapy Symptom Assessment Scale.;Diarrhea. Timepoint: Before starting the first or second chemotherapy sessions, and then in each chemotherapy session until 3 months - number of chemotherapy sessions depend on the chemotherapy protocol. Method of measurement: The Chemotherapy Symptom Assessment Scale.;Pain. Timepoint: Before starting the first or second chemotherapy sessions, and then in each chemotherapy session until 3 months - number of chemotherapy sessions depend on the chemotherapy protocol. Method of measurement: The Chemotherapy Symptom Assessment Scale.;Shortness of breath. Timepoint: Before starting the first or second chemotherapy sessions, and then in each chemotherapy session until 3 months - number of chemotherapy sessions depend on the chemotherapy protocol. Method of measurement: The Chemotherapy Symptom Assessment Scale.;Signs of infection. Timepoint: Before star | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMelika Babazadeh Zanjani
Tehran University of Medical Sciences
Outcome results
None listed